Condition

Apatinib clinical trials and research

As of November 12, 2026, Find a Trial lists 4 Apatinib clinical trials that are recruiting, in China. By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Apatinib clinical trials

StudyPhaseWhereStatusRegistered
Combining TACE with Camrelizumab and Apatinib for Liver Cancer Phase 3 Chengdu, Sichuan Recruiting Jul 3, 2024
Combination therapy for high-risk acral melanoma before surgery Phase 2 Beijing, Beijing Municipality Recruiting Aug 23, 2022
Apatinib as first-line therapy for elderly with advanced or metastatic gastric cancer Phase 2 Bengbu, Anhui Recruiting Jul 17, 2017
A halting of malignant ascites with apatinib in patients with cancer-related ascites Phase 2 Bengbu, Anhui Recruiting Jan 13, 2017

All recruiting trials (4)

Related topics

ApatinibCamrelizumabCamrelizumabAcral MelanomaGastric CancerMalignant AscitesMelanomaNeoadjuvantTransarterial ChemoembolizationUnresectable Hepatocellular Carcinoma

Quick answers

How many Apatinib clinical trials are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.